European Drug-Coated Stent Market Gets A Second Entrant In Guidant
This article was originally published in The Gray Sheet
Executive Summary
Guidant is significantly trimming Johnson & Johnson's early lead in getting a drug-coated stent to market by filing a European regulatory submission for its paclitaxel-coated stent